|
Volumn 9, Issue 12, 2014, Pages e115916-
|
Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden
a b b a b a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
AXL RECEPTOR TYROSINE KINASE;
ONCOPROTEIN;
PROTEIN TYROSINE KINASE;
TUMOR MARKER;
ADULT;
ANIMAL;
BLOOD;
CANCER TRANSPLANTATION;
FEMALE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
MORTALITY;
MOUSE;
NEURILEMOMA;
NEUROFIBROMA;
NEUROFIBROMATOSIS 1;
PATHOLOGY;
PHOSPHORYLATION;
PHOTOCHEMOTHERAPY;
PROGNOSIS;
SCHWANN CELL;
TUMOR CELL LINE;
TUMOR VOLUME;
XENOGRAFT;
ADULT;
ANIMALS;
BIOMARKERS, TUMOR;
CELL LINE, TUMOR;
FEMALE;
HUMANS;
MALE;
MICE;
MIDDLE AGED;
NEOPLASM TRANSPLANTATION;
NEURILEMMOMA;
NEUROFIBROMA, PLEXIFORM;
NEUROFIBROMATOSIS 1;
PHOSPHORYLATION;
PHOTOCHEMOTHERAPY;
PROGNOSIS;
PROTO-ONCOGENE PROTEINS;
RECEPTOR PROTEIN-TYROSINE KINASES;
SCHWANN CELLS;
TRANSPLANTATION, HETEROLOGOUS;
TUMOR BURDEN;
|
EID: 84990944636
PISSN: None
EISSN: 19326203
Source Type: Journal
DOI: 10.1371/journal.pone.0115916 Document Type: Article |
Times cited : (22)
|
References (0)
|